Author: Ravi Shankar

– MOU relates to a potential clinical trial in South Korea, Alpha DaRT’s first, at Samsung Medical Center (SMC) in Seoul, ranked fifth in the world and number one in Korea in oncology –

– In Korea, only about one in five pancreatic cancer patients undergo surgery, and the disease’s death rate rose over 6% in 2025, the steepest increase among major cancers –

JERUSALEM, Oct. 22, 2026 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, today announced the signing of an MOU in Seoul, South Korea, with Samsung Medical Center (SMC), regarding a potential clinical trial in pancreatic cancer patients. Any such trial would be subject to regulatory and ethics committee approvals.

Pancreatic cancer is one of Korea’s deadliest cancers. It is now the country’s fourth leading cause of cancer death, and unlike most cancers in Korea, its death rate has continued to rise. In 2023, 9,748 Koreans were diagnosed with the disease, and its five-year relative survival rate of 17.0% is the lowest of any cancer in the country. Fewer than one in six patients are diagnosed while the cancer is still confined to the pancreas, and more than four in ten are diagnosed only after it has already spread to distant organs.

SMC is ranked fifth in the world and number one in Korea in oncology. Its Pancreatobiliary Cancer Center combines a multidisciplinary team, a fast-track pathway for diagnosis and treatment, and a high-volume surgical program that has performed more than 4,000 pancreatectomies for pancreatic cancer between 2008 and 2025.(Courtesy of SMC)

Uzi Sofer, CEO of Alpha Tau, stated: “Signing this MOU with Samsung Medical Center, one of the world’s leading medical centers, is an important step forward in our goal to bring Alpha DaRT to cancer patients wherever they are. With Korea, our pancreatic cancer program could potentially span six countries across North America, Europe, the Middle East and Asia. I am grateful for SMC’s confidence in Alpha Tau and for the opportunity to explore the potential of Alpha DaRT to benefit its patients.”

Hee-Chul Kim, EVP of Samsung Medical Center, General Director of Samsung Comprehensive Cancer Center (SCCC), stated: “Pancreatic cancer remains one of the most challenging cancers to treat, and treatment options are limited for many patients. We hope this MOU will help us explore new possibilities for these patients. We will carefully review the clinical application of Alpha DaRT and do our best to strengthen our own research capabilities.”

About Alpha Tau Medical Ltd.

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company focused on the research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

About Alpha DaRT^®

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to primarily affect the tumor and to spare healthy tissue surrounding it.

About Samsung Comprehensive Cancer Center

Samsung Comprehensive Cancer Center (SCCC) is guided by respect for life, striving for excellence in patient care, research, and education to help people lead healthier, happier lives. Since opening in 2008 as Korea’s first and largest cancer center of its kind, SCCC has continued to expand its capabilities, establishing the Supportive Care Center (2014), the Proton Therapy Center (2016), the CAR T-Cell Therapy Center (2021), and the Precision Oncology Therapeutics Center (2022). In 2023, SCCC signed MOUs with Gustave Roussy and Charité to strengthen its global collaboration, and in 2024 it opened the Institute for Quality of Life in Cancer. In 2026, SCCC achieved ICHOM Level 1 accreditation and signed an MOU with EORTC. SMC was ranked fifth in the world and first in Korea in oncology in Newsweek’s World’s Best Specialized Hospitals 2027.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. When used herein, words including “anticipate,” “will,” “plan,” “may,” “continue,” and similar expressions are intended to identify forward-looking statements. Other than its marketing approval in Japan for unresectable locally advanced or locally recurrent head and neck cancer, the Alpha DaRT treatment has not been approved for commercialization or for use outside of an approved clinical trial. In addition, any statements or information that refer to the Alpha DaRT treatment in pancreatic cancer patients, including a potential collaboration with Samsung Medical Center, the planned clinical trial in Korea and the timing of the required regulatory and ethics committee approvals, the potential benefits and associated risks, safety, feasibility and efficacy, future applications and uses, and other expectations, beliefs and plans, including with respect to clinical trials, regulatory approvals and studies, are forward-looking. All forward-looking statements are based upon Alpha Tau’s current expectations and various assumptions. Alpha Tau believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. Alpha Tau may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors, including, without limitation: (i) Alpha Tau’s ability to receive regulatory approval for its Alpha DaRT technology or any future products or product candidates; (ii) Alpha Tau’s limited operating history; (iii) Alpha Tau’s incurrence of significant losses to date; (iv) Alpha Tau’s need for additional funding and ability to raise capital when needed; (v) Alpha Tau’s limited experience in medical device discovery and development; (vi) Alpha Tau’s dependence on the success and commercialization of the Alpha DaRT technology; (vii) the failure of preliminary data from Alpha Tau’s clinical studies to predict final study results; (viii) failure of Alpha Tau’s early clinical studies or preclinical studies to predict future clinical studies; (ix) Alpha Tau’s ability to enroll patients in its clinical trials; (x) undesirable side effects caused by Alpha Tau’s Alpha DaRT technology or any future products or product candidates; (xi) Alpha Tau’s exposure to patent infringement lawsuits; (xii) Alpha Tau’s ability to comply with the extensive regulations applicable to it; (xiii) the ability to meet Nasdaq’s listing standards; (xiv) costs related to being a public company; (xv) changes in applicable laws or regulations; and the other important factors discussed under the caption “Risk Factors” in Alpha Tau’s annual report filed on form 20-F with the SEC on March 9, 2026, and other filings that Alpha Tau may make with the United States Securities and Exchange Commission. These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While Alpha Tau may elect to update such forward-looking statements at some point in the future, except as required by law, it disclaims any obligation to do so, even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing Alpha Tau’s views as of any date subsequent to the date of this press release.

Investor Relations Contact:

IR@alphatau.com

Samsung Medical Center Media Contact:

Su-sung Kim, Team Leader, Communications Team, Samsung Medical Center, +82-2-3410-3042,

SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2026 earnings release and conference call.

The Company will release its third quarter 2026 results on Thursday, November 5, 2026, at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, November 5, 2026. The call can be accessed at 1-800-245-3047, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company’s website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.

About ICU Medical

ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.

CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John Mills, Managing Partner
(646) 277-1254

Source: ICU Medical, Inc.

LOWELL, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) — MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI) plans to announce financial results for its fourth quarter and fiscal year 2026, ended October 2, 2026, before the market open on Thursday, November 5, 2026. In conjunction with the release, MACOM will conduct a conference call at 8:30 a.m. Eastern Time that day, hosted by Mr. Stephen G. Daly, President and Chief Executive Officer, and Mr. John F. Kober, Senior Vice President and Chief Financial Officer.

Please visit MACOM’s Investor Relations Website to register for a user-specific access code for the live call or to access the live webcast. A replay of the call will be available within 24 hours and remain accessible by all interested parties for approximately 90 days.

About MACOM

MACOM designs and manufactures semiconductor products for telecommunications, industrial and defense and data center applications. Headquartered in Lowell, Massachusetts, MACOM has design centers and sales offices throughout North America, Europe and Asia. MACOM is certified to the ISO9001 international quality standard and ISO14001 environmental management standard. To learn more, visit https://www.macom.com/.

Company Contact:
MACOM Technology Solutions Holdings, Inc.
Stephen Ferranti, Senior Vice President, Corporate Development and Investor Relations
P: 978-656-2977
E: stephen.ferranti@macom.com

SHENZHEN, CHINA, Oct. 22, 2026 (GLOBE NEWSWIRE) — Lianhe Sowell International Group Ltd (Nasdaq: LHSW) (the “Company), a provider of industrial machine vision products and solutions in China, today announced that the Company will effectuate a 1-for-8 share consolidation of the Company’s ordinary shares of US$0.0016 par value each (the “Share Consolidation”).

Beginning with the opening of trading on October 26, 2026, the Company’s Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol “LHSW,” but under a new CUSIP number of G5480C120. The objective of the Share Consolidation is to maintain its listing on the Nasdaq Capital Market.

Upon the effectiveness of the Share Consolidation, every eight (8) Class A ordinary shares with a par value of US$0.0016 each will be consolidated into one (1) Class A ordinary share with a par value of US$0.0128 each, and every eight (8) Class B ordinary shares with a par value of US$0.0016 each will be consolidated into one (1) Class B ordinary share with a par value of US$0.0128 each. No fractional shares will be issued as a result of the Share Consolidation. Instead, any fractional shares that would have resulted from the Share Consolidation will be rounded up to the next whole number. Immediately prior to the Share Consolidation, as of the date hereof, the Company has a total of 22,878,354 Class A ordinary shares and 2,587,500 Class B ordinary shares issued and outstanding. As a result of the Share Consolidation, the Company will have approximately 2,859,795 Class A ordinary shares and 323,438 Class B ordinary shares issued and outstanding, subject to the rounding up of any fractional shares. The Share Consolidation affects all shareholders uniformly and will not alter any shareholder’s percentage interest in the Company’s outstanding ordinary shares, except for adjustments that may result from the treatment of fractional shares. The Share Consolidation was approved by the Company’s shareholders on May 28, 2026 and board of directors on October 6, 2026.

About Lianhe Sowell International Group Ltd

Lianhe Sowell International Group Ltd (Nasdaq: LHSW) provides industrial vision and industrial robotics solutions. With expertise in the field of machine vision and intelligent equipment, the Company specializes in smart transportation, industrial automation, artificial intelligence, and machine vision. Committed to offering comprehensive intelligent solutions to customers worldwide, the Company continuously advances the intelligent transformation of various industries through technological innovation. For more information, please visit: https://sowellai.com/.

Forward-Looking Statement

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may, “will, “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” “plan” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risk factors discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Lianhe Sowell International Group Ltd
Email: ir@cnsoftweIl.com

WFS Investor Relations Inc.
Email: services@wfsir.com 
Phone: +1 628 283 9214 

MIAMI, Oct. 22, 2026 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) (the “Company” or “GlobalX”), The Nation’s Fastest Growing Charter Airline^®, will host a conference call on Thursday, November 5, 2026 at 8:30 a.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2026. The Company’s results will be reported in a press release prior to the call.

GlobalX’s management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing JET@elevate-ir.com.

Date: Thursday, November 5, 2026
Time: 8:30 a.m. Eastern time
Toll-free dial-in number: (877) 709-8150
International dial-in number: (201) 689-8354
Webcast: GlobalX’s Q3 2026 Conference Call

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

The conference call will also be available for replay on the investor relations section of the Company’s website at www.globalairlinesgroup.com.

About Global Crossing Airlines Group, Inc.

GlobalX is a US 121 domestic flag and supplemental airline flying the Airbus A320 family of aircraft. The Company’s services include domestic and international ACMI and charter flights for passengers and cargo throughout the US, Caribbean, Europe, and Latin America. GlobalX is IOSA certified by IATA and holds TCOs for Europe, the UK, and Australia.

For more information:

Company Contact
Ryan Goepel, President & CFO
Tel: (720) 330-2829

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Email: JET@elevate-ir.com

Cautionary Note Regarding Forward-Looking Information

This press release contains certain “forward-looking statements” and “forward-looking information”, as defined under applicable United States and Canadian securities laws, concerning anticipated developments and events that may occur in the future. Forward-looking statements contained in this press release include, but are not limited to, statements with respect to the Company’s continued business expansion, the transition to a hybrid ownership model, the expected benefits of aircraft ownership, improving balance sheet and financial metrics, increasing demand, rapid scale in passenger operations, delivery timelines for aircraft, expected fleet size, receipt of FAA and DOT approvals and the Company’s status as the Nation’s fastest growing charter airline. In certain cases, forward-looking statements can be identified by the use of words such as “plans”, “expects” “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Forward-looking statements contained in this press release is based on certain factors and assumptions regarding, among other things, the receipt of financing to continue airline operations, the accuracy, reliability and success of GlobalX’s business model; GlobalX’s ability to accurately forecast demand; GlobalX will be able to successfully conclude definitive agreements for transactions subject to LOI; the timely receipt of governmental approvals, including from the FAA and DOT; the success of airline operations of GlobalX; GlobalX’s ability to successfully enter new geographic markets; the legislative and regulatory environments of the jurisdictions where GlobalX will carry on business or have operations; the Company has or will have sufficient aircraft to provide the service; the impact of competition and the competitive response to GlobalX’s business strategy; the future price of fuel, and the availability of aircraft. While the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. The Company has identified certain known material risk factors applicable to it in its Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC and its other filings with the SEC. Moreover, it is not always possible for the Company to predict how new risks and uncertainties that arise from time to time may affect it. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those described in the forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements are made as of the date of this press release. Except as required by applicable securities laws, the Company does not undertake any obligation to publicly update any forward-looking statements. If GlobalX does update one or more forward-looking statements, no inference should be made that it will make additional updates with respect to those or other forward-looking statements.

VANCOUVER, British Columbia, Oct. 22, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced that the Company’s management team will participate in the following upcoming conferences and host a virtual Analyst Day:

Craig Hallum Biotech Catalyst Virtual Conference (October 22^nd, 2026)
Format: Fireside Chat & 1×1 Meetings
Fireside Chat Date & Time: October 22, 2026, at 10:30am ET
Webcast link: Here
Location: Virtual

BIO-Europe (November 9-11, 2026)
Format: 1×1 Meetings
Location: Cologne, Germany

Stifel 2026 Healthcare Conference (November 10-12, 2026)
Format: Fireside Chat & 1×1 Meetings
Fireside Chat Date & Time: November 10, 2026, at 4:40pm ET
Webcast Link: Here
Location: New York, NY

Virtual Analyst Day to Discuss EP-104GI for Eosinophilic Esophagitis (November 13^th, 2026)
Format: Presentation
Presentation Date & Time: November 13, 2026, at 8:30am ET
Webcast Link: Here
Location: Virtual

2026 Jefferies Global Healthcare Conference in London (November 16-19, 2026)
Format: Presentation & 1×1 Meetings
Presentation Date & Time: November 16, 2026, at 1:30pm GMT
Webcast Link: Here
Location: London, UK

About Eupraxia Pharmaceuticals Inc.

Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Diffusphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians are wanting to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the Diffusphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia’s Diffusphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, to also be applicable in oncology, infectious disease and other critical disease areas.

EP-104GI and the Diffusphere™ technology platform are investigational products. Their effects on safety, tolerability, efficacy, and duration of effect have not been established and require evaluation in appropriate clinical studies.

Eupraxia’s EP-104GI is currently in a Phase 1b/2 trial, the RESOLVE trial, for the treatment of EoE. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. For further details about Eupraxia, please visit the Company’s website at: www.eupraxiapharma.com.

For investor and media inquiries, please contact:

Company and Investor Contact
James Meikle, Eupraxia Pharmaceuticals Inc.
236-330-7084
jmeikle@eupraxiapharma.com

or

Kevin Gardner, on behalf of:
Eupraxia Pharmaceuticals Inc.
617-283-2856
kgardner@lifesciadvisors.com

Media Contact 
Jason Braco, PhD 
Valence Communications 
jason@valencecomms.com 

FAIRFIELD, N.J., Oct. 22, 2026 (GLOBE NEWSWIRE) — Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company of Kearny Bank (the “Bank”), reported net income for the quarter ended September 30, 2026 of $10.0 million, or $0.16 per diluted share, compared to $7.2 million, or $0.11 per diluted share, for the quarter ended June 30, 2026.

The Company also announced that its Board of Directors declared a quarterly cash dividend of $0.11 per share, payable on November 18, 2026, to stockholders of record as of November 4, 2026.

Craig L. Montanaro, President and Chief Executive Officer, commented, “We are pleased to report continued progress this quarter, reflecting ongoing execution of our strategic plan, solid loan and deposit growth, and disciplined expense management. While our net interest margin reflected the impact of lower prepayment-related income and the repricing of our final remaining COVID-era wholesale funding position, our underlying margin drivers remain intact. Ongoing loan repricing and balance sheet remixing are expected to support further margin expansion in the quarters ahead.”

Mr. Montanaro continued, “Our strategic transformation continues to gain momentum as we deepen commercial client relationships, expand relationship-based deposit growth, and further reposition the balance sheet toward higher-yielding commercial and construction lending opportunities. During the quarter, we expanded our deposit-gathering capabilities with the launch of a dedicated Nonprofit and Independent Education Banking team. This initiative broadens access to attractive relationship-based funding sources and further diversifies our deposit franchise.”

First Quarter Highlights

• Net income increased 40.0% to $10.0 million, or $0.16 per diluted share.
• Pre-tax, pre-provision net revenue (non-GAAP) increased 14.0% to $13.5 million, or $0.21 per diluted share, reflecting ongoing strengthening of core earnings.
• Continued the strategic remixing of the loan portfolio, growing total loans by 7.2% on an annualized basis, while reducing multifamily mortgage exposure.
• Total deposits grew by 8.7% on an annualized basis, reflecting continued momentum across the Bank’s commercial deposit initiatives and supporting loan growth and balance sheet optimization.
• Launched a Nonprofit and Independent Education Banking team led by a seasoned industry professional with extensive experience serving mission-driven organizations through specialized banking solutions, further strengthening the Bank’s commercial banking capabilities.

Balance Sheet

• Total assets were $7.78 billion at September 30, 2026, an increase of $95.7 million, or 1.2%, from June 30, 2026.
• Investment securities totaled $1.04 billion at September 30, 2026, a decrease of $35.0 million, or 3.3%, from June 30, 2026.
• Loans receivable totaled $5.98 billion at September 30, 2026, an increase of $105.1 million, or 1.8%, from June 30, 2026.
• Deposits were $5.83 billion at September 30, 2026, an increase of $123.9 million, or 2.2%, from June 30, 2026, primarily driven by growth in interest-bearing demand deposits.
• Borrowings were $1.14 billion at September 30, 2026, a decrease of $15.0 million, or 1.3%, from June 30, 2026, reflecting reductions in overnight borrowings, partially offset by an increase in Federal Home Loan Bank (“FHLB”) advances.
• At September 30, 2026, the Company maintained available secured borrowing capacity with the FHLB and the Federal Reserve Discount Window of $2.21 billion, representing 28.5% of total assets.

Earnings

Net Interest Income and Net Interest Margin

• Average loan yields increased 10 basis points and average loan balances grew for the quarter ended September 30, 2026, contributing to an increase of $2.2 million, or 2.7%, in total interest income. Net interest margin was 2.23% for the quarter ended September 30, 2026, a decrease of three basis points from the prior quarter, as the benefit from higher asset yields was offset by the repricing of the Company’s final remaining COVID-era wholesale funding position and declines in purchase accounting accretion and loan prepayment penalty income, as described in further detail below.
• For the quarter ended September 30, 2026, net interest income decreased $294,000 to $40.1 million from $40.4 million for the quarter ended June 30, 2026. Included in net interest income for the quarters ended September 30, 2026 and June 30, 2026, respectively, was purchase accounting accretion of $396,000 and $537,000, and loan prepayment penalty income of $336,000 and $622,000. Excluding loan prepayment penalty income and purchase accounting accretion, net interest income increased $132,000 from the prior period.

Non-Interest Income

• For the quarter ended September 30, 2026, non-interest income decreased $110,000, or 2.1%, to $5.2 million from $5.3 million for the quarter ended June 30, 2026, primarily due to a non-recurring write-down of $122,000 on one other real estate owned property resulting from an updated appraisal. The remaining changes in non-interest income reflected normal operating fluctuations within those line items.

Non-Interest Expense

• For the quarter ended September 30, 2026, non-interest expense decreased $2.1 million, or 6.1%, to $31.8 million from $33.9 million for the quarter ended June 30, 2026, primarily driven by decreases in salary and benefits, advertising, equipment and systems, and other expense.
• Salary and benefits expense decreased $883,000 to $19.4 million for the quarter ended September 30, 2026 from $20.3 million for the quarter ended June 30, 2026, primarily driven by the absence of a $745,000 non-recurring severance charge recorded in the prior period and a $193,000 non-recurring decrease in stock-based compensation recorded in the current period. Excluding these items, salary and benefits expense remained relatively unchanged at $19.6 million for both periods.
• Advertising and marketing expense decreased $365,000 to $381,000 for the quarter ended September 30, 2026 from $746,000 for the quarter ended June 30, 2026, primarily driven by lower advertising expenses across various formats.
• Equipment and systems expense decreased $126,000 to $3.7 million for the quarter ended September 30, 2026 from $3.9 million for the quarter ended June 30, 2026, primarily driven by lower third-party core processing service fees.
• Other expense decreased $705,000 to $3.7 million for the quarter ended September 30, 2026 from $4.4 million for the quarter ended June 30, 2026, primarily driven by lower professional fees, provision for credit losses on unfunded commitments, and other real estate owned expenses. Changes in the other components of non-interest expense between comparative periods reflected normal operating fluctuations within those line items.

Income Taxes

• Income tax expense totaled $2.6 million for the quarter ended September 30, 2026 compared to $3.8 million for the quarter ended June 30, 2026, resulting in an effective tax rate of 20.7% and 34.9%, respectively. Income tax expense in the prior period included a $1.6 million valuation allowance against a deferred tax asset related to certain legacy stock-based compensation awards.

Asset Quality

• The balance of non-performing assets increased $3.2 million to $56.6 million, or 0.73% of total assets, at September 30, 2026 from $53.4 million, or 0.70% of total assets, at June 30, 2026.
• Net charge-offs totaled $277,000, or 0.02% of average loans, on an annualized basis, for the quarter ended September 30, 2026, compared to $49,000, or less than 0.01% of average loans, on an annualized basis, for the quarter ended June 30, 2026.
• For the quarter ended September 30, 2026, the Company recorded a provision for credit losses of $830,000, compared to $822,000 for the quarter ended June 30, 2026. The provision for credit loss expense for the quarter ended September 30, 2026 was primarily driven by loan growth.
• Allowance for credit losses (“ACL”) was $46.0 million, or 0.77% of total loans, at September 30, 2026, an increase of $553,000 from $45.5 million, or 0.77% of total loans, at June 30, 2026. The increase in the ACL from June 30, 2026 was primarily driven by a provision for credit losses, partially offset by loan charge-offs, as noted above.

Capital

• For the quarter ended September 30, 2026, book value per share decreased $0.20, or 1.7%, to $11.64 and tangible book value per share (non-GAAP) decreased $0.19, or 1.9%, to $9.88, primarily reflecting changes in the fair value of available-for-sale securities resulting from market interest rate movements during the quarter.
• At September 30, 2026, total stockholders’ equity included after-tax net unrealized losses on securities available for sale of $90.6 million, partially offset by after-tax unrealized gains on derivatives of $13.1 million. After-tax net unrecognized losses on securities held to maturity of $11.6 million were not reflected in total stockholders’ equity.
• At September 30, 2026, the Company’s tangible equity to tangible assets ratio (non-GAAP) equaled 8.37%. Additionally, the regulatory capital ratios of both the Company and the Bank continued to be in excess of all applicable regulatory requirements as of September 30, 2026.

This earnings release should be read in conjunction with Kearny Financial Corp.’s Q1 2027 Investor Presentation, a copy of which is available through the Investor Relations link located at the bottom of the page of our website at www.kearnybank.com and via a Current Report on Form 8-K on the website of the Securities and Exchange Commission at www.sec.gov.

Statements contained in this news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, factors discussed in documents filed by the Company with the Securities and Exchange Commission from time to time. The Company does not undertake and specifically disclaims any obligation to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

Linked-Quarter Comparative Financial Analysis
Kearny Financial Corp. Consolidated Balance Sheets (Unaudited)
(Dollars and Shares in Thousands, Except Per Share Data)	September 30, 2026			June 30, 2026			Variance or Change			Variance or Change Pct.
Assets
Cash and cash equivalents	$	115,829		$	114,823		$	1,006		0.9	%
Securities available for sale		931,965			964,369			(32,404	)	-3.4	%
Securities held to maturity		104,228			106,814			(2,586	)	-2.4	%
Loans held-for-sale		4,786			6,022			(1,236	)	-20.5	%
Loans receivable		5,980,398			5,875,325			105,073		1.8	%
Less: allowance for credit losses on loans		(46,049	)		(45,496	)		553		1.2	%
Net loans receivable		5,934,349			5,829,829			104,520		1.8	%
Premises and equipment		42,112			42,359			(247	)	-0.6	%
Federal Home Loan Bank stock		59,176			59,726			(550	)	-0.9	%
Accrued interest receivable		31,328			27,875			3,453		12.4	%
Goodwill		113,525			113,525			—		—	%
Core deposit intangible		857			968			(111	)	-11.5	%
Bank owned life insurance		317,512			314,756			2,756		0.9	%
Deferred income taxes, net		52,953			48,699			4,254		8.7	%
Other real estate owned		5,397			5,519			(122	)	-2.2	%
Other assets		63,885			46,921			16,964		36.2	%
Total assets	$	7,777,902		$	7,682,205		$	95,697		1.2	%
Liabilities
Deposits:
Non-interest-bearing	$	790,227		$	788,015		$	2,212		0.3	%
Interest-bearing		5,043,269			4,921,610			121,659		2.5	%
Total deposits		5,833,496			5,709,625			123,871		2.2	%
Borrowings		1,135,000			1,150,000			(15,000	)	-1.3	%
Advance payments by borrowers for taxes		18,640			18,562			78		0.4	%
Other liabilities		34,861			37,348			(2,487	)	-6.7	%
Total liabilities		7,021,997			6,915,535			106,462		1.5	%
Stockholders’ Equity
Common stock		649			648			1		0.2	%
Paid-in capital		495,513			495,953			(440	)	-0.1	%
Retained earnings		353,055			350,046			3,009		0.9	%
Unearned ESOP shares		(16,538	)		(17,025	)		487		2.9	%
Accumulated other comprehensive loss		(76,774	)		(62,952	)		(13,822	)	-22.0	%
Total stockholders’ equity		755,905			766,670			(10,765	)	-1.4	%
Total liabilities and stockholders’ equity	$	7,777,902		$	7,682,205		$	95,697		1.2	%
Consolidated capital ratios
Equity to assets		9.72	%		9.98	%		-0.26	%
Tangible equity to tangible assets (non-GAAP) (1)		8.37	%		8.62	%		-0.25	%
Share data
Outstanding shares		64,929			64,738			191		0.3	%
Book value per share	$	11.64		$	11.84		$	(0.20	)	-1.7	%
Tangible book value per share (non-GAAP) (2)	$	9.88		$	10.07		$	(0.19	)	-1.9	%

________________________
(1)   Tangible equity and tangible assets exclude goodwill and core deposit intangibles.
(2)   Tangible book value excludes goodwill and core deposit intangibles.

Kearny Financial Corp. Consolidated Statements of Income (Unaudited)
(Dollars and Shares in Thousands, Except Per Share Data)	Three Months Ended						Variance or Change			Variance or Change Pct.
	September 30, 2026			June 30, 2026
Interest income
Loans	$	71,425		$	69,376		$	2,049		3.0	%
Taxable investment securities		11,462			11,328			134		1.2	%
Tax-exempt investment securities		26			29			(3	)	-10.3	%
Other interest-earning assets		1,317			1,251			66		5.3	%
Total interest income		84,230			81,984			2,246		2.7	%
Interest expense
Deposits		31,923			30,537			1,386		4.5	%
Borrowings		12,227			11,073			1,154		10.4	%
Total interest expense		44,150			41,610			2,540		6.1	%
Net interest income		40,080			40,374			(294	)	-0.7	%
Provision for credit losses		830			822			8		1.0	%
Net interest income after provision for credit losses		39,250			39,552			(302	)	-0.8	%
Non-interest income
Fees and service charges		1,022			1,066			(44	)	-4.1	%
Gain on sale of loans		217			316			(99	)	-31.3	%
Loss on other real estate owned		(122	)		—			(122	)	—	%
Income from bank owned life insurance		2,756			2,706			50		1.8	%
Electronic banking fees and charges		464			460			4		0.9	%
Other income		866			765			101		13.2	%
Total non-interest income		5,203			5,313			(110	)	-2.1	%
Non-interest expense
Salaries and employee benefits		19,430			20,313			(883	)	-4.3	%
Net occupancy expense of premises		2,785			2,862			(77	)	-2.7	%
Equipment and systems		3,725			3,851			(126	)	-3.3	%
Advertising and marketing		381			746			(365	)	-48.9	%
Federal deposit insurance premium		1,425			1,360			65		4.8	%
Directors’ compensation		333			307			26		8.5	%
Other expense		3,708			4,413			(705	)	-16.0	%
Total non-interest expense		31,787			33,852			(2,065	)	-6.1	%
Income before income taxes		12,666			11,013			1,653		15.0	%
Income taxes		2,622			3,841			(1,219	)	-31.7	%
Net income	$	10,044		$	7,172		$	2,872		40.0	%
Net income per common share (EPS)
Basic	$	0.16		$	0.11		$	0.05
Diluted	$	0.16		$	0.11		$	0.05
Dividends declared
Cash dividends declared per common share	$	0.11		$	0.11		$	—
Cash dividends declared	$	7,035		$	7,008		$	27
Dividend payout ratio		70.0	%		97.7	%		-27.7	%
Weighted average number of common shares outstanding
Basic		63,122			62,958			164
Diluted		63,563			63,403			160

Kearny Financial Corp. Average Balance Sheet Data (Unaudited)
(Dollars in Thousands)	Three Months Ended						Variance or Change			Variance or Change Pct.
	September 30, 2026			June 30, 2026
Assets
Interest-earning assets:
Loans receivable, including loans held for sale	$	5,908,455		$	5,854,248		$	54,207		0.9	%
Taxable investment securities		1,171,085			1,185,569			(14,484	)	-1.2	%
Tax-exempt investment securities		4,344			4,759			(415	)	-8.7	%
Other interest-earning assets		115,794			109,098			6,696		6.1	%
Total interest-earning assets		7,199,678			7,153,674			46,004		0.6	%
Non-interest-earning assets		456,954			456,877			77		0.0	%
Total assets	$	7,656,632		$	7,610,551		$	46,081		0.6	%
Liabilities and Stockholders’ Equity
Interest-bearing liabilities:
Deposits:
Interest-bearing demand	$	2,272,168		$	2,207,264		$	64,904		2.9	%
Savings		748,945			760,770			(11,825	)	-1.6	%
Certificates of deposit (retail)		1,181,612			1,190,922			(9,310	)	-0.8	%
Certificates of deposit (brokered)		565,208			673,031			(107,823	)	-16.0	%
Total interest-bearing deposits		4,767,933			4,831,987			(64,054	)	-1.3	%
Borrowings:
Federal Home Loan Bank advances		1,137,228			1,022,637			114,591		11.2	%
Other borrowings		135,217			150,275			(15,058	)	-10.0	%
Total borrowings		1,272,445			1,172,912			99,533		8.5	%
Total interest-bearing liabilities		6,040,378			6,004,899			35,479		0.6	%
Non-interest-bearing liabilities:
Non-interest-bearing deposits		796,212			788,059			8,153		1.0	%
Other non-interest-bearing liabilities		56,617			54,614			2,003		3.7	%
Total non-interest-bearing liabilities		852,829			842,673			10,156		1.2	%
Total liabilities		6,893,207			6,847,572			45,635		0.7	%
Stockholders’ equity		763,425			762,979			446		0.1	%
Total liabilities and stockholders’ equity	$	7,656,632		$	7,610,551		$	46,081		0.6	%
Average interest-earning assets to average interest-bearing liabilities		119.19	%		119.13	%		0.06	%	0.1	%

Kearny Financial Corp. Performance Ratio Highlights (Unaudited)
	Three Months Ended				Variance or Change
	September 30, 2026		June 30, 2026
Average yield on interest-earning assets:
Loans receivable, including loans held for sale	4.84	%	4.74	%	0.10	%
Taxable investment securities	3.91	%	3.82	%	0.09	%
Tax-exempt investment securities (1)	2.43	%	2.40	%	0.03	%
Other interest-earning assets	4.55	%	4.59	%	-0.04	%
Total interest-earning assets	4.68	%	4.58	%	0.10	%
Average cost of interest-bearing liabilities:
Deposits:
Interest-bearing demand	2.54	%	2.49	%	0.05	%
Savings	1.27	%	1.34	%	-0.07	%
Certificates of deposit (retail)	3.19	%	3.17	%	0.02	%
Certificates of deposit (brokered)	4.03	%	2.87	%	1.16	%
Total interest-bearing deposits	2.68	%	2.53	%	0.15	%
Borrowings:
Federal Home Loan Bank advances	3.85	%	3.79	%	0.06	%
Other borrowings	3.77	%	3.71	%	0.06	%
Total borrowings	3.84	%	3.78	%	0.06	%
Total interest-bearing liabilities	2.92	%	2.77	%	0.15	%
Interest rate spread (2)	1.76	%	1.81	%	-0.05	%
Net interest margin (3)	2.23	%	2.26	%	-0.03	%
Non-interest income to average assets (annualized)	0.27	%	0.28	%	-0.01	%
Non-interest expense to average assets (annualized)	1.66	%	1.78	%	-0.12	%
Efficiency ratio (4)	70.20	%	74.09	%	-3.89	%
Return on average assets (annualized)	0.52	%	0.38	%	0.14	%
Return on average equity (annualized)	5.26	%	3.76	%	1.50	%
Return on average tangible equity (annualized) (5)	6.24	%	4.48	%	1.76	%

_________________________
(1)   The yield on tax-exempt investment securities has not been adjusted to reflect their tax-effective yield.
(2)   Interest income divided by average interest-earning assets less interest expense divided by average interest-bearing liabilities.
(3)   Net interest income divided by average interest-earning assets.
(4)   Non-interest expense divided by the sum of net interest income and non-interest income.
(5)   Average tangible equity excludes average goodwill and core deposit intangibles. See the “Reconciliation of GAAP to non-GAAP” table.

Five-Quarter Financial Trend Analysis
Kearny Financial Corp. Consolidated Balance Sheets
(Dollars and Shares in Thousands, Except Per Share Data)	September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
	(Unaudited)			(Audited)			(Unaudited)			(Unaudited)			(Unaudited)
Assets
Cash and cash equivalents	$	115,829		$	114,823		$	123,836		$	147,340		$	130,139
Securities available for sale		931,965			964,369			983,325			1,000,397			1,016,182
Securities held to maturity		104,228			106,814			110,581			112,800			116,681
Loans held-for-sale		4,786			6,022			12,183			8,786			6,650
Loans receivable		5,980,398			5,875,325			5,779,181			5,753,393			5,767,419
Less: allowance for credit losses on loans		(46,049	)		(45,496	)		(44,723	)		(44,958	)		(45,060	)
Net loans receivable		5,934,349			5,829,829			5,734,458			5,708,435			5,722,359
Premises and equipment		42,112			42,359			41,896			42,559			43,222
Federal Home Loan Bank stock		59,176			59,726			55,737			57,212			62,011
Accrued interest receivable		31,328			27,875			28,304			27,420			29,460
Goodwill		113,525			113,525			113,525			113,525			113,525
Core deposit intangible		857			968			1,080			1,198			1,317
Bank owned life insurance		317,512			314,756			312,050			309,404			307,248
Deferred income taxes, net		52,953			48,699			50,961			51,617			51,587
Other real estate owned		5,397			5,519			—			—			—
Other assets		63,885			46,921			39,720			40,185			47,629
Total assets	$	7,777,902		$	7,682,205		$	7,607,656		$	7,620,878		$	7,648,010
Liabilities
Deposits:
Non-interest-bearing	$	790,227		$	788,015		$	631,506		$	627,180		$	578,481
Interest-bearing		5,043,269			4,921,610			5,097,576			5,084,370			5,053,401
Total deposits		5,833,496			5,709,625			5,729,082			5,711,550			5,631,882
Borrowings		1,135,000			1,150,000			1,060,000			1,095,000			1,206,497
Advance payments by borrowers for taxes		18,640			18,562			19,317			18,474			19,261
Other liabilities		34,861			37,348			36,225			38,458			37,166
Total liabilities		7,021,997			6,915,535			6,844,624			6,863,482			6,894,806
Stockholders’ Equity
Common stock		649			648			648			648			648
Paid-in capital		495,513			495,953			495,442			494,959			494,490
Retained earnings		353,055			350,046			349,881			346,749			344,287
Unearned ESOP shares		(16,538	)		(17,025	)		(17,511	)		(17,997	)		(18,484	)
Accumulated other comprehensive loss		(76,774	)		(62,952	)		(65,428	)		(66,963	)		(67,737	)
Total stockholders’ equity		755,905			766,670			763,032			757,396			753,204
Total liabilities and stockholders’ equity	$	7,777,902		$	7,682,205		$	7,607,656		$	7,620,878		$	7,648,010
Consolidated capital ratios
Equity to assets		9.72	%		9.98	%		10.03	%		9.94	%		9.85	%
Tangible equity to tangible assets (non-GAAP) (1)		8.37	%		8.62	%		8.65	%		8.56	%		8.47	%
Share data
Outstanding shares		64,929			64,738			64,739			64,739			64,739
Book value per share	$	11.64		$	11.84		$	11.79		$	11.70		$	11.63
Tangible book value per share (non-GAAP) (2)	$	9.88		$	10.07		$	10.02		$	9.93		$	9.86

_________________________
(1)   Tangible equity and tangible assets exclude goodwill and core deposit intangibles.
(2)   Tangible book value excludes goodwill and core deposit intangibles.

Kearny Financial Corp. Supplemental Balance Sheet Highlights (Unaudited)
(Dollars in Thousands)	September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Loan portfolio composition:
Commercial loans:
Multi-family mortgage	$	2,436,745		$	2,499,894		$	2,555,001		$	2,619,124		$	2,640,737
Nonresidential mortgage		1,049,308			1,019,445			1,012,422			990,178			988,969
Commercial and industrial		231,361			223,927			201,277			169,884			142,304
Construction		303,007			263,200			207,765			181,766			189,626
Total commercial loans		4,020,421			4,006,466			3,976,465			3,960,952			3,961,636
One- to four-family residential mortgage		1,810,732			1,789,865			1,741,023			1,730,543			1,749,362
Consumer loans:
Home equity loans		76,827			79,844			61,379			59,046			54,116
Other consumer		77,397			2,387			2,377			2,523			2,487
Total consumer loans		154,224			82,231			63,756			61,569			56,603
Total loans, excluding yield adjustments		5,985,377			5,878,562			5,781,244			5,753,064			5,767,601
Unaccreted yield adjustments		(4,979	)		(3,237	)		(2,063	)		329			(182	)
Loans receivable, net of yield adjustments		5,980,398			5,875,325			5,779,181			5,753,393			5,767,419
Less: allowance for credit losses on loans		(46,049	)		(45,496	)		(44,723	)		(44,958	)		(45,060	)
Net loans receivable	$	5,934,349		$	5,829,829		$	5,734,458		$	5,708,435		$	5,722,359
Asset quality:
Nonperforming assets:
Accruing loans – 90 days and over past due	$	—		$	—		$	—		$	—		$	20,494
Nonaccrual loans		51,160			47,896			52,379			51,306			44,085
Total nonperforming loans		51,160			47,896			52,379			51,306			64,579
Other real estate owned		5,397			5,519			—			—			—
Total nonperforming assets	$	56,557		$	53,415		$	52,379		$	51,306		$	64,579
Nonperforming loans (% total loans)		0.86	%		0.82	%		0.91	%		0.89	%		1.12	%
Nonperforming assets (% total assets)		0.73	%		0.70	%		0.69	%		0.67	%		0.84	%
Classified loans	$	90,891		$	88,202		$	97,384		$	97,542		$	117,780
Allowance for credit losses on loans (ACL):
ACL to total loans		0.77	%		0.77	%		0.77	%		0.78	%		0.78	%
ACL to nonperforming loans		90.01	%		94.99	%		85.38	%		87.63	%		69.78	%
Net charge-offs	$	277		$	49		$	626		$	669		$	1,049
Average net charge-off rate (annualized)		0.02	%		0.00	%		0.04	%		0.05	%		0.07	%

Kearny Financial Corp. Supplemental Balance Sheet Highlights (Unaudited)
(Dollars in Thousands)	September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Funding composition:
Deposits:
Non-interest-bearing deposits	$	790,227		$	788,015		$	631,506		$	627,180		$	578,481
Interest-bearing demand		2,358,751			2,214,432			2,375,565			2,376,825			2,334,560
Savings		730,531			766,502			763,016			769,742			751,253
Certificates of deposit (retail)		1,198,701			1,183,427			1,201,752			1,180,370			1,208,408
Certificates of deposit (brokered)		755,286			757,249			757,243			757,433			759,180
Interest-bearing deposits		5,043,269			4,921,610			5,097,576			5,084,370			5,053,401
Total deposits		5,833,496			5,709,625			5,729,082			5,711,550			5,631,882
Borrowings:
Federal Home Loan Bank advances		1,025,000			950,000			900,000			800,000			1,006,497
Overnight borrowings		110,000			200,000			160,000			295,000			200,000
Total borrowings		1,135,000			1,150,000			1,060,000			1,095,000			1,206,497
Total funding	$	6,968,496		$	6,859,625		$	6,789,082		$	6,806,550		$	6,838,379
Loans as a % of deposits		101.8	%		102.2	%		100.3	%		100.1	%		101.7	%
Deposits as a % of total funding		83.7	%		83.2	%		84.4	%		83.9	%		82.4	%
Borrowings as a % of total funding		16.3	%		16.8	%		15.6	%		16.1	%		17.6	%
Uninsured deposits:
Uninsured deposits (reported) (1)	$	2,418,530		$	2,245,646		$	2,199,708		$	2,158,440		$	2,040,021
Uninsured deposits (adjusted) (2)	$	883,421		$	850,952		$	839,094		$	800,998		$	804,209

_________________________
(1)   Uninsured deposits of Kearny Bank.
(2)   Uninsured deposits of Kearny Bank adjusted to exclude deposits of its wholly-owned subsidiary and holding company and collateralized deposits of state and local governments.

Kearny Financial Corp. Consolidated Statements of Income (Unaudited)
	Three Months Ended
(Dollars and Shares in Thousands, Except Per Share Data)	September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Interest income
Loans	$	71,425		$	69,376		$	66,310		$	67,410		$	68,349
Taxable investment securities		11,462			11,328			11,425			11,623			12,600
Tax-exempt investment securities		26			29			34			35			41
Other interest-earning assets		1,317			1,251			1,400			1,584			1,518
Total interest income		84,230			81,984			79,169			80,652			82,508
Interest expense
Deposits		31,923			30,537			31,045			33,148			33,931
Borrowings		12,227			11,073			8,888			9,535			10,873
Total interest expense		44,150			41,610			39,933			42,683			44,804
Net interest income		40,080			40,374			39,236			37,969			37,704
Provision for (reversal of) credit losses		830			822			391			567			(82	)
Net interest income after provision for (reversal of) credit losses		39,250			39,552			38,845			37,402			37,786
Non-interest income
Fees and service charges		1,022			1,066			922			1,295			892
Gain on sale of loans		217			316			193			224			199
Loss on other real estate owned		(122	)		—			—			—			—
Income from bank owned life insurance		2,756			2,706			2,646			2,710			2,689
Electronic banking fees and charges		464			460			389			473			416
Other income		866			765			1,944			869			1,651
Total non-interest income		5,203			5,313			6,094			5,571			5,847
Non-interest expense
Salaries and employee benefits		19,430			20,313			19,316			18,373			18,745
Net occupancy expense of premises		2,785			2,862			3,263			2,888			3,307
Equipment and systems		3,725			3,851			3,975			4,007			3,974
Advertising and marketing		381			746			665			412			562
Federal deposit insurance premium		1,425			1,360			1,302			1,357			1,301
Directors’ compensation		333			307			307			306			307
Other expense		3,708			4,413			3,471			3,848			3,470
Total non-interest expense		31,787			33,852			32,299			31,191			31,666
Income before income taxes		12,666			11,013			12,640			11,782			11,967
Income taxes		2,622			3,841			2,503			2,333			2,461
Net income	$	10,044		$	7,172		$	10,137		$	9,449		$	9,506
Net income per common share (EPS)
Basic	$	0.16		$	0.11		$	0.16		$	0.15		$	0.15
Diluted	$	0.16		$	0.11		$	0.16		$	0.15		$	0.15
Dividends declared
Cash dividends declared per common share	$	0.11		$	0.11		$	0.11		$	0.11		$	0.11
Cash dividends declared	$	7,035		$	7,008		$	7,005		$	6,987		$	6,963
Dividend payout ratio		70.0	%		97.7	%		69.1	%		73.9	%		73.2	%
Weighted average number of common shares outstanding
Basic		63,122			62,958			62,908			62,858			62,741
Diluted		63,563			63,403			63,251			63,061			62,951

Kearny Financial Corp. Average Balance Sheet Data (Unaudited)
	Three Months Ended
(Dollars in Thousands)	September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Assets
Interest-earning assets:
Loans receivable, including loans held-for-sale	$	5,908,455		$	5,854,248		$	5,785,095		$	5,778,680		$	5,806,767
Taxable investment securities		1,171,085			1,185,569			1,194,487			1,185,602			1,236,705
Tax-exempt investment securities		4,344			4,759			5,669			5,902			6,856
Other interest-earning assets		115,794			109,098			106,967			123,475			115,776
Total interest-earning assets		7,199,678			7,153,674			7,092,218			7,093,659			7,166,104
Non-interest-earning assets		456,954			456,877			455,725			455,752			453,215
Total assets	$	7,656,632		$	7,610,551		$	7,547,943		$	7,549,411		$	7,619,319
Liabilities and Stockholders’ Equity
Interest-bearing liabilities:
Deposits:
Interest-bearing demand	$	2,272,168		$	2,207,264		$	2,402,177		$	2,385,397		$	2,343,809
Savings		748,945			760,770			761,090			759,247			754,244
Certificates of deposit (retail)		1,181,612			1,190,922			1,181,526			1,201,950			1,211,026
Certificates of deposit (brokered)		565,208			673,031			755,461			756,179			755,813
Total interest-bearing deposits		4,767,933			4,831,987			5,100,254			5,102,773			5,064,892
Borrowings:
Federal Home Loan Bank advances		1,137,228			1,022,637			861,445			998,760			1,077,146
Other borrowings		135,217			150,275			133,833			38,478			85,489
Total borrowings		1,272,445			1,172,912			995,278			1,037,238			1,162,635
Total interest-bearing liabilities		6,040,378			6,004,899			6,095,532			6,140,011			6,227,527
Non-interest-bearing liabilities:
Non-interest-bearing deposits		796,212			788,059			633,494			595,035			581,625
Other non-interest-bearing liabilities		56,617			54,614			59,644			59,447			65,024
Total non-interest-bearing liabilities		852,829			842,673			693,138			654,482			646,649
Total liabilities		6,893,207			6,847,572			6,788,670			6,794,493			6,874,176
Stockholders’ equity		763,425			762,979			759,273			754,918			745,143
Total liabilities and stockholders’ equity	$	7,656,632		$	7,610,551		$	7,547,943		$	7,549,411		$	7,619,319
Average interest-earning assets to average interest-bearing liabilities		119.19	%		119.13	%		116.35	%		115.53	%		115.07	%

Kearny Financial Corp. Performance Ratio Highlights
	Three Months Ended
	September 30, 2026		June 30, 2026		March 31, 2026		December 31, 2025		September 30, 2025
Average yield on interest-earning assets:
Loans receivable, including loans held-for-sale	4.84	%	4.74	%	4.58	%	4.67	%	4.71	%
Taxable investment securities	3.91	%	3.82	%	3.83	%	3.92	%	4.08	%
Tax-exempt investment securities (1)	2.43	%	2.40	%	2.37	%	2.36	%	2.42	%
Other interest-earning assets	4.55	%	4.59	%	5.24	%	5.13	%	5.24	%
Total interest-earning assets	4.68	%	4.58	%	4.47	%	4.55	%	4.61	%
Average cost of interest-bearing liabilities:
Deposits:
Interest-bearing demand	2.54	%	2.49	%	2.34	%	2.51	%	2.63	%
Savings	1.27	%	1.34	%	1.26	%	1.40	%	1.41	%
Certificates of deposit (retail)	3.19	%	3.17	%	3.20	%	3.45	%	3.56	%
Certificates of deposit (brokered)	4.03	%	2.87	%	2.71	%	2.72	%	2.67	%
Total interest-bearing deposits	2.68	%	2.53	%	2.43	%	2.60	%	2.68	%
Borrowings:
Federal Home Loan Bank advances	3.85	%	3.79	%	3.56	%	3.66	%	3.69	%
Other borrowings	3.77	%	3.71	%	3.66	%	4.13	%	4.44	%
Total borrowings	3.84	%	3.78	%	3.57	%	3.68	%	3.74	%
Total interest-bearing liabilities	2.92	%	2.77	%	2.62	%	2.78	%	2.88	%
Interest rate spread (2)	1.76	%	1.81	%	1.85	%	1.77	%	1.73	%
Net interest margin (3)	2.23	%	2.26	%	2.21	%	2.14	%	2.10	%
Non-interest income to average assets (annualized)	0.27	%	0.28	%	0.32	%	0.30	%	0.31	%
Non-interest expense to average assets (annualized)	1.66	%	1.78	%	1.71	%	1.65	%	1.66	%
Efficiency ratio (4)	70.20	%	74.09	%	71.25	%	71.64	%	72.71	%
Return on average assets (annualized)	0.52	%	0.38	%	0.54	%	0.50	%	0.50	%
Return on average equity (annualized)	5.26	%	3.76	%	5.34	%	5.01	%	5.10	%
Return on average tangible equity (annualized) (5)	6.24	%	4.48	%	6.34	%	5.96	%	6.09	%

_________________________
(1)   The yield on tax-exempt investment securities has not been adjusted to reflect their tax-effective yield.
(2)   Interest income divided by average interest-earning assets less interest expense divided by average interest-bearing liabilities.
(3)   Net interest income divided by average interest-earning assets.
(4)   Non-interest expense divided by the sum of net interest income and non-interest income.
(5)   Average tangible equity excludes average goodwill and core deposit intangibles. See the “Reconciliation of GAAP to non-GAAP” table.

The following tables provide a reconciliation of certain financial measures calculated in accordance with Generally Accepted Accounting Principles (“GAAP”) (as reported) and non-GAAP measures. These non-GAAP measures provide additional information which allow readers to evaluate the ongoing performance of the Company. They are not a substitute for GAAP measures; they should be read and used in conjunction with the Company’s GAAP financial information. In all cases, it should be understood that non-GAAP per share measures do not depict amounts that accrue directly to the benefit of shareholders.

Kearny Financial Corp. Reconciliation of GAAP to Non-GAAP (Unaudited)
	Three Months Ended
(Dollars and Shares in Thousands, Except Per Share Data)	September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Adjusted net income:
Net income (GAAP)	$	10,044		$	7,172		$	10,137		$	9,449		$	9,506
Non-recurring transactions – net of tax:
Branch consolidation expenses		—			—			—			—			178
Severance expense from workforce realignment		—			529			—			—			—
Deferred tax asset valuation allowance		—			1,562			—			—			—
Gain on sale of property held for sale		—			—			(724	)		—			(532	)
Adjusted net income	$	10,044		$	9,263		$	9,413		$	9,449		$	9,152
Calculation of pre-tax, pre-provision net revenue:
Net income (GAAP)	$	10,044		$	7,172		$	10,137		$	9,449		$	9,506
Adjustments to net income (GAAP):
Provision for income taxes		2,622			3,841			2,503			2,333			2,461
Provision for (reversal of) credit losses		830			822			391			567			(82	)
Pre-tax, pre-provision net revenue (non-GAAP)	$	13,496		$	11,835		$	13,031		$	12,349		$	11,885
Adjustments to pre-tax, pre-provision net revenue (non-GAAP):
Branch consolidation expenses	$	—		$	—		$	—		$	—		$	250
Severance expense from workforce realignment		—			745			—			—			—
Gain on sale of property held for sale		—			—			(1,020	)		—			(749	)
Pre-tax, pre-provision net revenue (non-GAAP) – adjusted	$	13,496		$	12,580		$	12,011		$	12,349		$	11,386
Adjusted earnings per share:
Weighted average common shares – basic		63,122			62,958			62,908			62,858			62,741
Weighted average common shares – diluted		63,563			63,403			63,251			63,061			62,951
Earnings per share – basic (GAAP)	$	0.16		$	0.11		$	0.16		$	0.15		$	0.15
Earnings per share – diluted (GAAP)	$	0.16		$	0.11		$	0.16		$	0.15		$	0.15
Adjusted earnings per share – basic (non-GAAP)	$	0.16		$	0.15		$	0.15		$	0.15		$	0.15
Adjusted earnings per share – diluted (non-GAAP)	$	0.16		$	0.15		$	0.15		$	0.15		$	0.15
Pre-tax, pre-provision net revenue per share:
Pre-tax, pre-provision net revenue per share – basic (non-GAAP)	$	0.21		$	0.19		$	0.21		$	0.20		$	0.19
Pre-tax, pre-provision net revenue per share – diluted (non-GAAP)	$	0.21		$	0.19		$	0.21		$	0.20		$	0.19
Pre-tax, pre-provision net revenue per share – basic (non-GAAP) – adjusted	$	0.21		$	0.20		$	0.19		$	0.20		$	0.18
Pre-tax, pre-provision net revenue per share – diluted (non-GAAP) – adjusted	$	0.21		$	0.20		$	0.19		$	0.20		$	0.18
Adjusted return on average assets:
Total average assets	$	7,656,632		$	7,610,551		$	7,547,943		$	7,549,411		$	7,619,319
Return on average assets (GAAP)		0.52	%		0.38	%		0.54	%		0.50	%		0.50	%
Adjusted return on average assets (non-GAAP)		0.52	%		0.49	%		0.50	%		0.50	%		0.48	%
Adjusted return on average equity:
Total average equity	$	763,425		$	762,979		$	759,273		$	754,918		$	745,143
Return on average equity (GAAP)		5.26	%		3.76	%		5.34	%		5.01	%		5.10	%
Adjusted return on average equity (non-GAAP)		5.26	%		4.86	%		4.96	%		5.01	%		4.91	%

Kearny Financial Corp. Reconciliation of GAAP to Non-GAAP (Unaudited)
	Three Months Ended
(Dollars and Shares in Thousands, Except Per Share Data)	September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Adjusted return on average tangible equity:
Total average equity	$	763,425		$	762,979		$	759,273		$	754,918		$	745,143
Less: average goodwill		(113,525	)		(113,525	)		(113,525	)		(113,525	)		(113,525	)
Less: average other intangible assets		(930	)		(1,042	)		(1,157	)		(1,276	)		(1,395	)
Total average tangible equity	$	648,970		$	648,412		$	644,591		$	640,117		$	630,223
Return on average tangible equity (non-GAAP)		6.24	%		4.48	%		6.34	%		5.96	%		6.09	%
Adjusted return on average tangible equity (non-GAAP)		6.24	%		5.77	%		5.90	%		5.96	%		5.87	%
Adjusted non-interest expense ratio:
Non-interest expense (GAAP)	$	31,787		$	33,852		$	32,299		$	31,191		$	31,666
Non-recurring transactions:
Branch consolidation expenses		—			—			—			—			(250	)
Severance expense from workforce realignment		—			(745	)		—			—			—
Non-interest expense (non-GAAP)	$	31,787		$	33,107		$	32,299		$	31,191		$	31,416
Non-interest expense ratio (GAAP)		1.66	%		1.78	%		1.71	%		1.65	%		1.66	%
Adjusted non-interest expense ratio (non-GAAP)		1.66	%		1.74	%		1.71	%		1.65	%		1.65	%
Adjusted efficiency ratio:
Non-interest expense (non-GAAP)	$	31,787		$	33,107		$	32,299		$	31,191		$	31,416
Net interest income (GAAP)	$	40,080		$	40,374		$	39,236		$	37,969		$	37,704
Total non-interest income (GAAP)		5,203			5,313			6,094			5,571			5,847
Non-recurring transactions:
Gain on sale of property held for sale		—			—			(1,020	)		—			(749	)
Total revenue (non-GAAP)	$	45,283		$	45,687		$	44,310		$	43,540		$	42,802
Efficiency ratio (GAAP)		70.20	%		74.09	%		71.25	%		71.64	%		72.71	%
Adjusted efficiency ratio (non-GAAP)		70.20	%		72.46	%		72.89	%		71.64	%		73.40	%

For further information contact:
Sean Byrnes, Executive Vice President and Chief Financial Officer
Kearny Financial Corp.
(973) 244-4500

SAN DIEGO, Oct. 22, 2026 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV) (“NeoVolta” or the “Company”), a U.S.-based energy technology company delivering scalable energy storage solutions, today announced the launch of a third-party-ownership (TPO) financing platform funded by tax equity partners and designed to deploy solar and battery energy storage for both residential and commercial & industrial (C&I) customers. The TPO platform launches with an initial focus on the residential market; NeoVolta plans to extend the platform to support its C&I product line as its domestic manufacturing facility in Pendergrass, Georgia, ramps production.

Key Highlights

• Initial $40-million financing platform with tax equity partner expected to support approximately 700 residential storage and solar-plus-storage projects.
• Built as a third-party-ownership (TPO) platform for both residential and commercial & industrial (C&I) customers, preserving access to the federal Section 48E tax credit as the market shifts away from cash and loan purchases.
• NV Wave, NeoVolta’s next-generation residential battery platform already shipping to customers, will be integrated into the TPO offering beginning in November 2026.
• Launches with an initial focus on residential, with plans to extend the platform to NeoVolta’s C&I product line as its Georgia manufacturing facility ramps production.

The residential launch comes as the U.S. residential energy storage market continues to shift from cash and loan purchases toward third-party-owned (TPO) structures. Aurora Solar’s 2026 Solar Snapshot survey found 55% of installers now call TPO their leading residential financing option, driven in part by the Section 25D tax credit’s expiration for homeowner-owned systems placed in service after Dec. 31, 2025, while the Section 48E credit remains available to the owner of a third-party-owned system. NeoVolta also plans to begin integrating NV Wave, its next-generation residential battery energy storage product, which has received FEOC compliance confirmation and domestic content certification, into the TPO offering starting in November 2026.

The company is launching with an initial $40-million financing platform expected to support approximately 700 residential projects. Its initial pipeline includes contracted projects for income-qualified California homeowners eligible for the state’s Self-Generation Incentive Program (SGIP) rebates. As of Sept. 30, the Company has deployed projects in over 50 homes.

The TPO platform is managed with support from Luminia, NeoVolta’s longtime energy financing and deployment partner, bringing together NeoVolta’s energy storage capabilities with Luminia’s experience in renewable energy financing, project deployment including its installer network and third-party ownership programs.

“The residential energy market has changed, but the need for affordable, reliable solar and battery energy storage has not,” said Ardes Johnson, Chief Executive Officer of NeoVolta. “Our TPO platform is built to serve both our residential and C&I customers, and we’re launching it with residential. Residential remains a critical piece of our business: a near-term revenue driver as our Georgia manufacturing facility ramps production, and a long-term pillar of our growth and our brand alongside our commercial and utility-scale platforms. We also plan to extend the TPO platform to support our C&I product line as production ramps at Pendergrass. It is a new way to keep bringing these technologies to customers while expanding NeoVolta beyond equipment sales into deployment and recurring energy services, a natural extension of our Build and Deploy strategy.”

“The TPO platform brings financing, installation and ongoing support together in one offering, giving customers a simpler and more affordable way to access solar and battery storage without buying and managing the equipment themselves,” said David Field, Chief Executive Officer of Luminia. “By simplifying the process and providing long-term support, we can help more customers take control of their energy costs.”

For NeoVolta, the TPO platform establishes a scalable channel for deploying energy storage across its residential and C&I businesses while participating in a broader portion of the project lifecycle, and is intended to be the first of a series of tax equity partners funded financing vehicles designed to accelerate NeoVolta’s residential and commercial energy storage deployments. The platform’s initial offering includes residential solar-plus-storage and standalone battery storage, with C&I offerings to follow as the platform expands.

About NeoVolta

NeoVolta is an innovator in energy storage solutions dedicated to advancing reliable, high-performance power infrastructure for residential, commercial, and utility applications. With a focus on scalable technology, domestic manufacturing, and strategic partnerships, NeoVolta is positioned to support the accelerating transition toward resilient energy systems.

For more information, visit www.neovolta.com.

About Luminia

Headquartered in San Diego, Luminia is a renewable energy developer accelerating the transition to local commercial and community-based solar and energy storage. Luminia partners with homeowners, businesses, commercial real-estate owners, Community Choice Aggregators (CCAs) and local communities to design, finance, build and operate portfolios of distributed clean energy projects that deliver energy savings, resiliency, grid stability and lasting value.

For more information, visit https://luminia.io.

Forward-Looking Statements

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements include, among others, statements regarding  the anticipated scale and performance of the TPO platform, the timing and availability of the NV Wave residential battery platform, the planned extension of the TPO platform to NeoVolta’s C&I product line, the continued availability and treatment of federal tax incentives such as Section 48E, and NeoVolta’s broader deployment, financing and product strategy. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately,” or other words that convey uncertainty of future events or outcomes. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. Risk Factors in the Company’s most recently filed Form 10-K and updated from time to time in its Form 10-Q filings and in its other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. The Company undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Contacts

NEOV Investors
Bryan Baritot
Alliance Advisors IR
ir@neovolta.com  

NEOV Media
Email: press@neovolta.com
Phone: 800-364-5464

New FI-3000 FiberInspector Pro MMC inspection tips provide access to hard-to-reach connections, eliminating the need to disconnect multiple fibers to gain access

Everett, Washington, Oct. 22, 2026 (GLOBE NEWSWIRE) — As AI, cloud and high-speed networking drive higher fiber density in data centers, technicians installing or troubleshooting fiber connections need to inspect connector end faces hidden within densely populated patch panels. The process increases troubleshooting time, operational complexity and the risk of network disruption. To address these challenges, Fluke Networks today announced new inspection tips for the FI-3000 FiberInspector™ Pro, enabling access to MMC fiber connections in high-density environments without disturbing critical network infrastructure.

The new portfolio consists of two MMCE extended-reach inspection tips, available in keyed and keyless versions, that eliminate one of the most common challenges in high-density data centers: accessing fiber connectors for inspection without disturbing active infrastructure. The tips provide direct access to bulkhead connectors and patch panel ports from the front of the rack, reducing the need to disconnect multiple fiber assemblies while accelerating troubleshooting and helping protect network uptime.

Contaminated fiber remains one of the leading causes of optical network performance issues. In an NTT-Advanced Technology study, 96% of installers and 80% of network operators reported problems related to connector end-face contamination. As connector density increases, so does the challenge of inspecting and maintaining fiber connections. Multi-fiber connectors create more opportunities for contamination while making access and inspection more difficult. The new MMC inspection tips help technicians follow fiber inspection best practices, inspect hard-to-reach connectors and maintain fiber quality without adding workflow complexity.

“The industry’s push toward greater fiber density is transforming data center infrastructure, but it’s also creating new challenges for the teams responsible for keeping networks running reliably,” said Mark Mullins, Global Product Manager, Fluke Networks. “Technicians shouldn’t have to disrupt installed infrastructure just to inspect a fiber connection. With these new FI-3000 inspection tips, we’re removing a longstanding operational tradeoff by enabling access to hard-to-reach MMC connectors from the front of the rack. That means faster installation and troubleshooting, less complexity and greater confidence that critical networks remain online and performing as expected.”

Together, the new inspection tips help reduce the operational burden associated with maintaining and troubleshooting fiber infrastructure. Rather than disconnecting adjacent connections to gain access or spending time locating the correct fiber from the back of a rack, technicians can inspect connectors directly through the front of populated patch panels. This streamlined workflow helps accelerate commissioning, troubleshooting and routine maintenance activities.

The MMC tips are designed for use with the FI-3000 FiberInspector Ultra, part of Versiv™, the industry’s leading Cabling Certification platform, which also supports twisted pair cabling along with single-and multifiber connections.  Contractors using the platform report minimal training time and Fluke offers factory-certified training with over 10,000 certified technicians worldwide. Documentation of results is offered through LinkWare™, the most widely accepted reporting software with nearly 40,000 downloads and nearly 200 million results stored.

To learn more about the new MMC inspection tips for the FI-3000 FiberInspector Pro and how they simplify inspection of critical fiber connections in high-density data center environments, please visit FI-3000 FiberInspector Pro MMC Inspection Tips.

About Fluke
Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measurement and condition monitoring. Fluke customers include technicians, engineers, electricians, maintenance managers and metrologists who install, troubleshoot and maintain industrial, electrical and electronic equipment and calibration processes.

###

FLUKE is a registered trademark of Fluke Corporation. For more information, visit www.fluke.com.

Media Contacts:
Dave Smith
Fluke Corporation
dave.smith@fluke.com

Olivia Kline
Fluke Corporation
olivia.kline@fluke.com

Q: What is the FI-3000 FiberInspector™ Pro?
A: The FI-3000 FiberInspector™ Pro is a fiber inspection solution that helps technicians identify contamination and defects on fiber connector end faces before they impact network performance, reliability or certification results. Automated pass/fail analysis and interchangeable inspection tips enable fast, consistent inspection across a wide range of fiber connector types.

Q: What challenges are the new FI-3000 FiberInspector™ Pro tips designed to address?
A: As data centers increase fiber density to support AI, cloud and high-speed networking, technicians often have to disconnect multiple fiber connections or work through crowded racks to access connectors for inspection. The new inspection tips provide direct access to hard-to-reach MMC connectors, reducing complexity, troubleshooting time and the risk of network disruption.

Q: What benefits do the new FI-3000 inspection tips deliver to customers?
A: The new tips make it easier to inspect critical fiber connections without disconnecting active infrastructure. Customers can accelerate maintenance and troubleshooting, improve adherence to fiber inspection best practices, maintain fiber quality and help protect network reliability and uptime.

Attachments

• Fluke’s new FI-3000 FiberInspector Pro MMC inspection tips provide access to hard-to-reach connections
• Fluke’s new FI-3000 FiberInspector Pro MMC inspection tips provide access to hard-to-reach connections

CONTACT: Dave Smith
Fluke Corporation
dave.smith@fluke.com

NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) — via AINewsWire — ECGI Holdings Inc. (OTC: ECGI) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

To view the full publication, “How Artificial Intelligence Is Reshaping Preventive Care Across the U.S.,” please visit: https://ibn.fm/OXnvD

In today’s healthcare landscape, treating sickness after the fact is giving way to stopping it before it starts. U.S. health spending hit $5.3 trillion in 2024, and Medicare Advantage enrolls 35.2 million people today, equal to 55% of those eligible. For 2026, KFF estimates Medicare Advantage payments will hit $574 billion, giving health plans strong financial incentive to keep their members well.

A new category of company is emerging to meet that shift. ECGI Holdings Inc. has finalized its purchase of Avanta Group, an emerging platform combining a Medicare Advantage health plan with management services and AI-driven health technology. Through the acquisition, ECGI gains direct entry into coordinated, proactive care right as the broader industry looks for better ways to deliver it.

About ECGI Holdings Inc.

ECGI Holdings is a technology-driven investment and development company focused on building innovative, technology-enabled businesses with sustainable, long-term revenue models. Its portfolio and strategic interests span high-growth sectors including artificial intelligence and fintech.

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

For more information, visit ECGI Holdings.

About AINewsWire

AINewsWire (AINW) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

DISCLAIMER: AINewsWire (AINW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by AINW are solely those of AINW. Readers of this Article and content agree that they cannot and will not seek to hold liable AINW for any investment decisions by their readers or subscribers. AINW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, AINW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

AINW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and AINW undertakes no obligation to update such statements.

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: 
https://www.AINewsWire.com/Disclaimer

AINewsWire
Austin, Texas
www.AINewsWire.com
512.354.7000 Office
Editor@AINewsWire.com

AINewsWire is powered by IBN